CN Stock MarketDetailed Quotes

301263 Guangdong Taienkang Pharmaceutical

Watchlist
  • 12.99
  • +0.37+2.93%
Market Closed Jun 7 15:00 CST
5.53BMarket Cap35.98P/E (TTM)

Guangdong Taienkang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Guangdong Taienkang Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

189.11M

-2.41%
EPS(YoY)

0.11

-50.00%
Analyst Rating

Strong Buy

Jun 8, 2024

Guangdong Taienkang Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.505B--
--2024/FY-- / 1.168B--
--2023/FY760.787M / 976.000M--
--2022/FY783.480M / 858.500M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.505B--
--2024/FY-- / 1.168B--
--2023/FY760.787M / 976.000M--
--2022/FY783.480M / 858.500M--

Guangdong Taienkang Pharmaceutical Earnings Reports

  • Taienkang: Report for the first quarter of 2024

    Apr 22 12:00 ET

  • Taienkang: 2023 Annual Report Summary

    Apr 22 12:00 ET

  • Taienkang: Annual Report 2023

    Apr 22 12:00 ET

  • Taienkang: 2023 Third Quarter Report

    Oct 29, 2023 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 8, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg